AbbVie
ABBV
#25
Rank
โ‚ฌ344.40 B
Marketcap
195,09ย โ‚ฌ
Share price
-0.24%
Change (1 day)
18.83%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Net assets

Net assets on the balance sheet as of December 2024 : โ‚ฌ3.10 Billion

According to AbbVie's latest financial reports the company has โ‚ฌ3.10 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

AbbVie - Net assets on balance sheet (from 2011 to 2024)

Net assets by year

Year Net assets Change
2024-12-31$โ‚ฌ3.23 B-65.63%
2023-12-31$โ‚ฌ9.40 B-41.64%
2022-12-31$โ‚ฌ16.11 B18.24%
2021-12-31$โ‚ฌ13.62 B28%
2020-12-31$โ‚ฌ10.64 B-245.97%
2019-12-31$-โ‚ฌ7.3 Billion-1.19%
2018-12-31$-โ‚ฌ7.39 Billion-273.8%
2017-12-31$โ‚ฌ4.24 B-3.62%
2016-12-31$โ‚ฌ4.40 B22.16%
2015-12-31$โ‚ฌ3.60 B151.9%
2014-12-31$โ‚ฌ1.43 B-55.97%
2013-12-31$โ‚ฌ3.25 B27.94%
2012-12-31$โ‚ฌ2.54 B-72.33%
2011-12-31$โ‚ฌ9.18 B-22.17%
2010-12-31$โ‚ฌ11.80 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
โ‚ฌ81.61 B 2,530.71%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ15.11 B 387.16%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ13.16 B 324.24%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ5.41 B 74.70%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ17.74 B 472.12%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ15.41 B 396.91%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ15.14 B 388.16%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚ฌ37.69 B 1,114.95%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚ฌ2.38 B-23.02%๐Ÿ‡บ๐Ÿ‡ธ USA